Cargando…
Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention
Approximately 5–20% of HNSCC patients experience second primary cancers within the first 5 years of treatment, contributing to high mortality rates. Epidemiological evidence has linked a low dietary intake of antioxidants to an increased risk of cancer, especially squamous cell carcinoma, prompting...
Autores principales: | Meliante, Piero Giuseppe, Petrella, Carla, Fiore, Marco, Minni, Antonio, Barbato, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525582/ https://www.ncbi.nlm.nih.gov/pubmed/37760056 http://dx.doi.org/10.3390/antiox12091753 |
Ejemplares similares
-
Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
por: Meliante, Piero Giuseppe, et al.
Publicado: (2022) -
Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021) -
Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)